Type
|
Subsidiary |
---|---|
Traded as | NYSE: KATE |
Industry | Fashion |
Founded | New York City, New York (1976) |
Headquarters | New York City, New York, United States |
Key people
|
Craig Leavitt (CEO) George M. Carrara (COO) Deborah Lloyd (CCO) |
Products | Clothing Accessories Perfumes |
Revenue | 1,242.72 million USD (2015) |
Net income
|
17.09 million (2015) |
Number of employees
|
6,800 (2014) |
Parent | Coach Inc. |
Website | katespadeandcompany.com |
Kate Spade & Company, initially known as Liz Claiborne Inc. (founded in 1976 in Manhattan), and then as Fifth & Pacific Companies until February 25, 2014, is a fashion company that designs and markets a range of women's and men's apparel, accessories and fragrance products under the Kate Spade New York and Jack Spade labels.
Liz Claiborne Inc. was founded in 1976 by Liz Claiborne, Art Ortenberg, Leonard Boxer, and Jerome Chazen. In 1980, Nina McLemore founded Liz Claiborne Accessories. Liz Claiborne Inc. went public in 1981 and had made the Fortune 500 list in 1986, ten years after it was founded, with retail sales of $1.2 billion.
After retiring in 1989, Claiborne died on June 26, 2007, at the age of 78 from complications from cancer.
On May 15, 2012, Liz Claiborne Inc. officially became Fifth & Pacific, Inc. and shifted focus to three brands – Juicy Couture, Kate Spade New York, and Lucky Brand Jeans.
On October 7, 2013, Fifth & Pacific Cos announced that they would sell Juicy Couture to Authentic Brands Group for $195 million. In December, the company announced it was selling Lucky Brand Jeans for $225 million to Leonard Green & Partners, leaving the Kate Spade businesses as the company's sole label.
On February 25, 2014, Fifth & Pacific was renamed Kate Spade & Company. Craig A. Leavitt succeeded William McComb, whose retirement marked the official end of the company's transformation from Liz Claiborne to Kate Spade.
Founder Leonard Boxer retired in 1985, and in 1989, Liz Claiborne and Art Ortenberg also retired from active management. Jerome Chazen became the company's Chairman in 1989 and held that role until 1996, when Paul Charron became Chairman and C.E.O. and held that position until 2006. During Charron's tenure Liz Claiborne, Inc. acquired Lucky Brand Jeans in 1999. In 2001, they acquired Mexx and in 2003 they bought another small fashion company, Juicy Couture. The company acquired kate spade in 2006. On October 16, 2006, Liz Claiborne Inc. named William McComb, a Johnson & Johnson veteran, the company's Chief Executive Officer.
On October 8, 2009, JC Penney Co. (based out of Plano, TX), announced that it would become the exclusive retailer for the Liz Claiborne brand. All Liz Claiborne merchandise would exit any additional department-store retailer, and the Liz Claiborne New York designed by Isaac Mizrahi would move from department stores to QVC. The Liz&Co. and Concepts by Claiborne brands originally exclusively sold at JC Penney would be phased out, and the Liz Claiborne merchandise would begin appearing in JC Penney stores in August 2010. In October 2011, the company completed the sale of its Dana Buchman brand to Kohl's. In November 2011, the Company announced that it has completed the transaction to sell domestic and international trademark rights of its Liz Claiborne family of brands and domestic trademark rights of its Monet brand to JC Penney. In 2013, Fifth & Pacific narrowed its focus to the Kate Spade brand by selling both Juicy Couture and Lucky Brand Jeans, returning to a mono-brand company.
Deborah Lloyd, formerly of Banana Republic and Burberry, joined kate spade New York in 2007 and leads the creative aspects of the brand as president and chief creative officer. In this role, she oversees all creative aspects, including product design, merchandising and creative services.
Craig A. Leavitt, currently chief executive officer, joined shortly thereafter.
The Kate Spade & Company portfolio of brands today includes Kate Spade New York and Jack Spade. The Adelington Design Group, a private-label jewelry design and development group, is also operated by the company. It markets brands through department stores, and serves J. C. Penney, via an exclusive license for Liz Claiborne and Monet jewelry lines, and Kohl's with a license for Dana Buchman jewelry.
2016-06-27 | Reiterated Rating | Cowen and Company | Outperform | $30.00 |
2016-06-04 | Reiterated Rating | Citigroup Inc. | Buy | $33.00 |
2016-05-16 | Reiterated Rating | Citigroup Inc. | Buy | |
2016-05-12 | Reiterated Rating | Buckingham Research | Buy | $31.00 |
2016-05-05 | Reiterated Rating | Oppenheimer | Hold | |
2016-05-05 | Downgrade | Stephens | Overweight to Equal Weight | |
2016-05-05 | Boost Price Target | Goldman Sachs | Neutral | $21.00 to $22.00 |
2016-05-05 | Boost Price Target | Citigroup Inc. | Buy | $32.00 to $33.00 |
2016-05-05 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
2016-05-05 | Boost Price Target | Goldman Sachs Group Inc. | Neutral | $21.00 to $22.00 |
2016-04-25 | Reiterated Rating | Cowen and Company | Outperform | |
2016-04-22 | Boost Price Target | Mizuho | Buy | $25.00 to $30.00 |
2016-04-14 | Reiterated Rating | Citigroup Inc. | Focus List to Buy | $26.00 to $32.00 |
2016-04-12 | Initiated Coverage | Buckingham Research | Buy | $31.00 |
2016-04-08 | Boost Price Target | KeyBanc | $27.00 | |
2016-04-08 | Boost Price Target | KeyCorp | $27.00 | |
2016-03-16 | Reiterated Rating | Wells Fargo | Market Perform | |
2016-03-16 | Reiterated Rating | Wells Fargo & Co. | Market Perform | |
2016-03-04 | Lower Price Target | Wolfe Research | Outperform | $29.00 to $27.00 |
2016-03-03 | Boost Price Target | Barclays | Overweight | $23.00 to $28.00 |
2016-03-03 | Boost Price Target | Barclays PLC | Overweight | $23.00 to $28.00 |
2016-03-02 | Boost Price Target | Nomura | Buy | $23.00 to $26.00 |
2016-03-02 | Reiterated Rating | Wedbush | Outperform | $32.00 to $30.00 |
2016-03-02 | Reiterated Rating | Cowen and Company | Buy | |
2016-03-02 | Boost Price Target | Nomura Holdings Inc. | Buy | $23.00 to $26.00 |
2016-03-01 | Reiterated Rating | Mizuho | Buy | |
2016-02-02 | Lower Price Target | Barclays | Overweight | $41.00 to $23.00 |
2016-01-22 | Lower Price Target | Mizuho | Buy | $30.00 to $25.00 |
2016-01-05 | Reiterated Rating | Wedbush | Outperform | $32.00 |
2015-12-29 | Reiterated Rating | Wedbush | Overweight | $32.00 |
2015-12-17 | Initiated Coverage | Goldman Sachs | Neutral | $20.00 |
2015-12-03 | Reiterated Rating | Citigroup Inc. | Buy | $34.00 to $38.00 |
2015-11-05 | Reiterated Rating | Mizuho | Buy | $30.00 |
2015-11-02 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | |
2015-10-21 | Initiated Coverage | Wells Fargo | Market Perform | |
2015-10-14 | Initiated Coverage | Wolfe Research | Outperform | $29.00 |
2015-09-24 | Upgrade | Stephens | Equal Weight to Overweight | |
2015-09-22 | Reiterated Rating | Wedbush | Outperform | $32.00 |
2015-09-18 | Reiterated Rating | Wunderlich | Buy | $39.00 |
2015-08-11 | Reiterated Rating | Citigroup Inc. | Buy | $33.00 |
2015-08-07 | Reiterated Rating | SunTrust | Neutral | $32.00 to $25.00 |
2015-08-07 | Reiterated Rating | SunTrust Banks Inc. | Neutral | $32.00 to $25.00 |
2015-08-06 | Lower Price Target | SunTrust | Neutral | $32.00 to $25.00 |
2015-08-05 | Reiterated Rating | Citigroup Inc. | Buy | |
2015-08-04 | Reiterated Rating | Wunderlich | Buy | $39.00 |
2015-08-03 | Reiterated Rating | Wedbush | Outperform | $32.00 |
2015-08-03 | Lower Price Target | Monness Crespi & Hardt | Buy | $37.00 to $27.00 |
2015-07-31 | Lower Price Target | Mizuho | Buy | $40.00 to $30.00 |
2015-07-27 | Reiterated Rating | Barclays | Overweight | $41.00 |
2015-07-14 | Downgrade | OTR Global | Positive | |
2015-07-09 | Initiated Coverage | Cleveland Research | Buy | |
2015-06-30 | Reiterated Rating | Cowen and Company | Buy | |
2015-06-24 | Reiterated Rating | Sterne Agee CRT | Buy | $37.00 |
2015-06-01 | Reiterated Rating | Cowen and Company | Buy | $37.00 |
2015-05-28 | Initiated Coverage | Oppenheimer | Market Perform | |
2015-05-27 | Initiated Coverage | BB&T Corp. | Buy | |
2015-05-27 | Initiated Coverage | BBVA | Buy | $35.00 |
2015-05-26 | Initiated Coverage | BB&T Corp. | Buy | $35.00 |
2015-05-14 | Initiated Coverage | Wedbush | Outperform | |
2015-05-13 | Initiated Coverage | Wedbush | Outperform | $39.00 to $39.00 |
2015-05-12 | Initiated Coverage | Bank of America | Buy | |
2015-05-12 | Initiated Coverage | Bank of America Corp. | Buy | |
2015-05-11 | Reiterated Rating | Nomura | Buy | $36.00 |
2015-05-10 | Reiterated Rating | Mizuho | Buy | $40.00 |
2015-05-07 | Reiterated Rating | Wunderlich | Buy | $39.00 |
2015-03-03 | Boost Price Target | Wunderlich | Buy | $36.00 to $39.00 |
2015-03-03 | Boost Price Target | Mizuho | Buy | $36.00 to $38.00 |
2015-02-02 | Upgrade | Monness Crespi & Hardt | Neutral to Buy | $37.00 |
2015-02-02 | Boost Price Target | Citigroup Inc. | Buy | $34.00 to $38.00 |
2015-01-23 | Upgrade | Mizuho | Neutral to Buy | $28.00 to $33.00 |
2015-01-08 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $48.00 to $32.00 |
2014-12-16 | Initiated Coverage | Cowen and Company | Outperform | $35.00 |
2014-12-09 | Initiated Coverage | Stephens | Equal Weight | |
2014-11-24 | Upgrade | Bank of America | Neutral to Buy | $33.00 to $34.00 |
2014-11-07 | Reiterated Rating | Barclays | Overweight | $50.00 to $41.00 |
2014-11-07 | Reiterated Rating | Bank of America | Neutral | $28.00 to $33.00 |
2014-11-03 | Reiterated Rating | Wunderlich | Buy | $36.00 |
2014-10-30 | Initiated Coverage | Mizuho | Neutral | $28.00 |
2014-10-21 | Initiated Coverage | Bank of America | Neutral | $28.00 |
2014-09-17 | Initiated Coverage | Wunderlich | Buy | $36.00 |
2014-08-13 | Lower Price Target | Telsey Advisory Group | Not Rated | $43.00 to $38.00 |
2014-08-13 | Reiterated Rating | Nomura | Buy | $43.00 to $38.00 |
2014-08-13 | Reiterated Rating | Citigroup Inc. | Buy | $44.00 to $34.00 |
2014-07-08 | Initiated Coverage | BMO Capital Markets | Outperform | $48.00 |
2014-05-15 | Boost Price Target | Telsey Advisory Group | Not Rated | $40.00 to $43.00 |
2014-05-15 | Reiterated Rating | Nomura | Buy | $41.00 to $43.00 |
2014-05-15 | Reiterated Rating | Citigroup Inc. | Buy | $42.00 to $44.00 |
2014-05-02 | Initiated Coverage | Nomura | Buy | $41.00 |
2014-03-18 | Initiated Coverage | Barclays | Overweight | $50.00 |
2014-03-03 | Upgrade | Citigroup Inc. | Neutral to Buy | |
2014-02-26 | Boost Price Target | BB&T Corp. | $38.00 to $41.00 | |
2014-02-26 | Boost Price Target | Telsey Advisory Group | Not Rated | $38.00 to $40.00 |
2014-02-26 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | |
2014-01-10 | Downgrade | Brean Capital | Buy to Hold | |
2013-12-12 | Boost Price Target | Wedbush | $40.00 | |
2013-12-10 | Boost Price Target | Imperial Capital | Outperform | $30.00 to $40.00 |
2013-11-20 | Reiterated Rating | Wedbush | Buy | $32.00 |
2013-11-20 | Boost Price Target | KeyBanc | Buy | $34.00 to $37.00 |
2013-11-11 | Boost Price Target | BB&T Corp. | Buy | $30.00 to $38.00 |
2013-11-08 | Boost Price Target | Wedbush | Outperform | $27.00 to $32.00 |
2013-11-08 | Boost Price Target | Monness Crespi & Hardt | Buy | $27.00 to $33.00 |
2013-11-08 | Boost Price Target | KeyBanc | Buy | $28.00 to $34.00 |
2013-11-08 | Boost Price Target | Brean Capital | $30.00 to $33.00 | |
2013-10-08 | Boost Price Target | Sterne Agee CRT | Buy | $28.00 to $30.00 |
2013-10-07 | Reiterated Rating | KeyBanc | Buy | $28.00 |
2016-06-27 | Reiterated Rating | Cowen and Company | Outperform | $30.00 |
2016-06-04 | Reiterated Rating | Citigroup Inc. | Buy | $33.00 |
2016-05-16 | Reiterated Rating | Citigroup Inc. | Buy | |
2016-05-12 | Reiterated Rating | Buckingham Research | Buy | $31.00 |
2016-05-05 | Reiterated Rating | Oppenheimer | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In KATE 20 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 4.93M |
BlackRock Institutional Trust Company, N.A. | 3.93M |
KCG Holdings, Inc. | 0.49M |
BlackRock Investment Management, LLC | 0.45M |
Airain ltd | 0.43M |
MANAGED ACCOUNT ADVISORS LLC | 0.29M |
BLACKROCK ADVISORS LLC | 0.25M |
BlackRock Group LTD | 0.18M |
Pinnacle Summer Investments, Inc. | 0.15M |
Shinko Asset Management Co., Ltd. | 74830 |
RUSSELL FRANK CO/ | 61652 |
Caerus Global Investors LLC | 50324 |
BOSTON PRIVATE BANK & TRUST CO | 36564 |
Spot Trading L.L.C | 29500 |
CAPSTONE ASSET MANAGEMENT CO | 23295 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
KOPLOVITZ KAY | 0.15% (191381) | CA / KATE / TIME / |
MARTINEZ ARTHUR C | 0.08% (106680) | AIG / ANF / HSNI / IACI / IFF / KATE / |
Warren Andrew Chief Financial Officer | 0.07% (88978) | KATE / |
McComb William L Chief Executive Officer | 0.07% (86403) | KATE / |
ARONSON BERNARD W | 0.06% (73126) | CLAC / KATE / NTI / RCL / |
JONES EVON L SVP, Chief Information Officer | 0.03% (34805) | KATE / |
Rubino Nicholas SVP, Chief Legal Officer | 0.02% (31580) | KATE / VNCE / |
GOODELL ELAINE H Corporate Controller and CAO | 0.02% (20158) | KATE / |
Rinaldo Michael D VP, Corp. Controller & CAO | 0.01% (16976) | KATE / |
Vill Robert J SVP, Finance & Treasurer | 0.01% (13729) | KATE / |
Higley William J SVP, Human Resources | 0.01% (8819) | KATE / |